Microbial ribosomal vaccines.

Research output: Contribution to journalArticle

38 Citations (Scopus)

Abstract

Ribosomal vaccines have been prepared from several different bacterial, fungal, and protozoan microorganisms. Most of these preparations offer a higher degree of protection than do vaccines made from the homologous whole cells, but the mode of protection is controversial. All of the reported ribosomal vaccines are contaminated with cell surface determinants. Antisera raised to ribosomal preparations are directed to innate ribosomal components as well as to surface antigens. Several hypotheses exist for the reported protection from disease: the cell surface contaminants serve as the protective moieties; ribosomes act as potent adjuvants for contaminating cell surface determinants; ribosomes innately contain antigenic determinants that cross-react with cell surface antigens; recently translated cell surface polypeptides are still attached to the ribosomal RNA in the ribosomes; ribosomes migrate from the cytoplasm of the microbe to the periphery of the cell, and ribosomal antigens are exposed on the cell surface; or ribosomes contain messenger RNA and produce microbial cell surface polypeptides in immunized individuals. A short description of the biochemical, biophysical, and structural characteristics of prokaryotic and eukaryotic ribosomes is presented, followed by a discussion of the ability of various ribosomal vaccines to protect against infectious agents.

Original languageEnglish
Pages (from-to)208-217
Number of pages10
JournalReviews of Infectious Diseases
Volume8
Issue number2
StatePublished - Mar 1986
Externally publishedYes

Fingerprint

Ribosomes
Vaccines
Cytoprotection
Surface Antigens
Peptides
Ribosomal RNA
Immune Sera
Epitopes
Cytoplasm
Antigens
Messenger RNA

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Microbial ribosomal vaccines. / Gregory, Richard.

In: Reviews of Infectious Diseases, Vol. 8, No. 2, 03.1986, p. 208-217.

Research output: Contribution to journalArticle

@article{eaff1d7ffbd44e10ad116fc68443bec4,
title = "Microbial ribosomal vaccines.",
abstract = "Ribosomal vaccines have been prepared from several different bacterial, fungal, and protozoan microorganisms. Most of these preparations offer a higher degree of protection than do vaccines made from the homologous whole cells, but the mode of protection is controversial. All of the reported ribosomal vaccines are contaminated with cell surface determinants. Antisera raised to ribosomal preparations are directed to innate ribosomal components as well as to surface antigens. Several hypotheses exist for the reported protection from disease: the cell surface contaminants serve as the protective moieties; ribosomes act as potent adjuvants for contaminating cell surface determinants; ribosomes innately contain antigenic determinants that cross-react with cell surface antigens; recently translated cell surface polypeptides are still attached to the ribosomal RNA in the ribosomes; ribosomes migrate from the cytoplasm of the microbe to the periphery of the cell, and ribosomal antigens are exposed on the cell surface; or ribosomes contain messenger RNA and produce microbial cell surface polypeptides in immunized individuals. A short description of the biochemical, biophysical, and structural characteristics of prokaryotic and eukaryotic ribosomes is presented, followed by a discussion of the ability of various ribosomal vaccines to protect against infectious agents.",
author = "Richard Gregory",
year = "1986",
month = "3",
language = "English",
volume = "8",
pages = "208--217",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "2",

}

TY - JOUR

T1 - Microbial ribosomal vaccines.

AU - Gregory, Richard

PY - 1986/3

Y1 - 1986/3

N2 - Ribosomal vaccines have been prepared from several different bacterial, fungal, and protozoan microorganisms. Most of these preparations offer a higher degree of protection than do vaccines made from the homologous whole cells, but the mode of protection is controversial. All of the reported ribosomal vaccines are contaminated with cell surface determinants. Antisera raised to ribosomal preparations are directed to innate ribosomal components as well as to surface antigens. Several hypotheses exist for the reported protection from disease: the cell surface contaminants serve as the protective moieties; ribosomes act as potent adjuvants for contaminating cell surface determinants; ribosomes innately contain antigenic determinants that cross-react with cell surface antigens; recently translated cell surface polypeptides are still attached to the ribosomal RNA in the ribosomes; ribosomes migrate from the cytoplasm of the microbe to the periphery of the cell, and ribosomal antigens are exposed on the cell surface; or ribosomes contain messenger RNA and produce microbial cell surface polypeptides in immunized individuals. A short description of the biochemical, biophysical, and structural characteristics of prokaryotic and eukaryotic ribosomes is presented, followed by a discussion of the ability of various ribosomal vaccines to protect against infectious agents.

AB - Ribosomal vaccines have been prepared from several different bacterial, fungal, and protozoan microorganisms. Most of these preparations offer a higher degree of protection than do vaccines made from the homologous whole cells, but the mode of protection is controversial. All of the reported ribosomal vaccines are contaminated with cell surface determinants. Antisera raised to ribosomal preparations are directed to innate ribosomal components as well as to surface antigens. Several hypotheses exist for the reported protection from disease: the cell surface contaminants serve as the protective moieties; ribosomes act as potent adjuvants for contaminating cell surface determinants; ribosomes innately contain antigenic determinants that cross-react with cell surface antigens; recently translated cell surface polypeptides are still attached to the ribosomal RNA in the ribosomes; ribosomes migrate from the cytoplasm of the microbe to the periphery of the cell, and ribosomal antigens are exposed on the cell surface; or ribosomes contain messenger RNA and produce microbial cell surface polypeptides in immunized individuals. A short description of the biochemical, biophysical, and structural characteristics of prokaryotic and eukaryotic ribosomes is presented, followed by a discussion of the ability of various ribosomal vaccines to protect against infectious agents.

UR - http://www.scopus.com/inward/record.url?scp=0022689670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022689670&partnerID=8YFLogxK

M3 - Article

VL - 8

SP - 208

EP - 217

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 2

ER -